Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS – OPERATING ACTIVITIES    
Net loss $ (12,856) $ (12,772)
Adjustments required to reconcile cash flows used in operating activities:    
Depreciation and amortization 560 440
Stock-based compensation 254 446
Amortization of debt issuance costs 331
Finance income, net (506) (180)
Revaluation of contingent consideration (2) 2
Income from change in fair value of Private Placement Warrants (3,858)
Private Placement Warrants issuance cost 732
Change in contract liability (1,976)
Loss from sale of fixed assets, net 97
Changes in operating assets and liabilities:    
Other current and non-current assets 803 59
Trade accounts payable (2,229) 1,353
Other accounts payable (2,921) 1,238
Net change in operating leases (691) (39)
Net cash used in operating activities (22,593) (9,122)
CASH FLOWS – INVESTING ACTIVITIES    
Cash and Restricted Cash acquired from the APT acquisition 663
Proceeds from short-term deposits 2,000
Proceeds from sale of fixed assets 63
Purchases of property and equipment (9) (11)
Net cash provided by investing activities 717 1,989
CASH FLOWS – FINANCING ACTIVITIES    
Issuance of Private Placement Warrants under March 2024 PIPE 28,745
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE 21,269
March 2024 PIPE issuance costs (507)
Issuance costs from February 2023 PIPE (301)
Issuance of Common Stock and Warrants under February 2023 PIPE 7,485
Pre-Funded Warrants exercise 6
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs 19
Issuance cost from the APT acquisition (13)
Repayment of long-term debt (10,747) (1,654)
Net cash provided by financing activities 38,772 5,530
Increase(decrease) in cash and cash equivalents and restricted cash 16,896 (1,603)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (46) (29)
Cash and cash equivalents and restricted cash at the beginning of the period 15,864 32,294
Cash and cash equivalents and restricted cash at the end of the period 32,714 30,662
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 31,611 29,711
Restricted cash 1,103 951
Total cash and cash equivalents and restricted cash 32,714 30,662
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 1,419 992
Taxes paid 7 14
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance costs from February 2023 PIPE included in trade accounts payable 32
Property and equipment purchases included in accounts payable and Trade payable 10 29
Issuance cost from March 2024 PIPE 1,685
Issuance cost from the APT acquisition 38
Issuance of Common Stock under the APT acquisition 3,041
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition 12,610
Issuance of Merger Warrants under the APT acquisition $ 200